3-(2,4-dimethoxybenzylidene)anabaseine and Central Nervous System Disease

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Central Nervous System Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, DJ; Arneric, SP; Bannon, AW; Briggs, CA; Brioni, JD; Decker, MW; Donnelly-Roberts, D; Holladay, MW; Sullivan, JP; Williams, M	1

Reviews

1 review(s) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Central Nervous System Disease

Article	Year
Cholinergic channel activators: novel opportunities for the treatment of CNS disorders. Proceedings of the Western Pharmacology Society, 1995, Volume: 38 Topics: Animals; Anti-Anxiety Agents; Benzylidene Compounds; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Diseases; Cholinergic Antagonists; Humans; Ion Channels; Isoxazoles; Nicotinic Agonists; Parasympathetic Nervous System; Pyridines; Pyrrolidines; Receptors, Cholinergic	1995

Article

Year

Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.

Proceedings of the Western Pharmacology Society, 1995, Volume: 38

Topics: Animals; Anti-Anxiety Agents; Benzylidene Compounds; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Diseases; Cholinergic Antagonists; Humans; Ion Channels; Isoxazoles; Nicotinic Agonists; Parasympathetic Nervous System; Pyridines; Pyrrolidines; Receptors, Cholinergic

1995